Onward Medical N.V.

As of June 30, 2026, Onward Medical N.V. carries a market capitalization of 174.86M, placing it among publicly traded companies globally. Its enterprise value stands at 107.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Onward Medical N.V.'s next confirmed earnings release is scheduled for March 3, 2027.

As of June 30, 2026, Onward Medical N.V. has 69.53M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Onward Medical N.V. maintains a current ratio of 9.23, meaning it holds 9.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 23, 2026, Onward Medical N.V.'s stock has declined approximately 59.73% over the past 52 weeks. The 50-day moving average sits at 2.51, while the 200-day moving average is 3.01.

As of June 30, 2026, Onward Medical N.V. holds 81.51M in cash and equivalents against 13.79M in total debt, resulting in a net debt position of -15.22M. Total book value stands at 71.94M, with working capital of 80.13M providing operational flexibility.